Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
- Clear Street analyst Greg Pendy initiated coverage on Rocket Lab Corp (NASDAQ:RKLB) with a Buy rating and announced a price target of $88. Rocket Lab shares closed at $69.48 on Wednesday. See how other analysts view this stock.
- Truist Securities analyst Srikripa Devarakonda initiated coverage on Inventiva (NASDAQ:IVA) with a Buy rating and announced a price target of $13. Inventiva shares closed at $5.96 on Wednesday. See how other analysts view this stock.
- B. Riley Securities analyst John Massocca initiated coverage on FrontView REIT Inc (NYSE:FVR) with a Buy rating and announced a price target of $20.5. FrontView shares closed at $16.08 on Wednesday. See how other analysts view this stock.
- Macquarie analyst Steve Koenig initiated coverage on Okta Inc (NASDAQ:OKTA) with an Outperform rating and announced a price target of $100. Okta shares closed at $78.43 on Wednesday. See how other analysts view this stock.
- Wells Fargo analyst Sadia Rahman initiated coverage on Dianthus Therapeutics Inc (NASDAQ:DNTH) with an Overweight rating and announced a price target of $135. Dianthus Therapeutics shares closed at $78.86 on Wednesday. See how other analysts view this stock.
Considering buying RKLB stock? Here’s what analysts think:

Photo via Shutterstock
Login to comment